{"name":"Cipla BioTec Pvt. Ltd.","slug":"cipla-biotec-pvt-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"CBT124","genericName":"CBT124","slug":"cbt124","indication":"unknown","status":"phase_3"},{"name":"US Sourced Avastin®","genericName":"US Sourced Avastin®","slug":"us-sourced-avastin","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"EU-sourced Avastin®","genericName":"EU-sourced Avastin®","slug":"eu-sourced-avastin","indication":"Metastatic colorectal cancer","status":"phase_3"}]}],"pipeline":[{"name":"CBT124","genericName":"CBT124","slug":"cbt124","phase":"phase_3","mechanism":"CBT124 is a small molecule that targets the molecular target.","indications":["unknown"],"catalyst":""},{"name":"EU-sourced Avastin®","genericName":"EU-sourced Avastin®","slug":"eu-sourced-avastin","phase":"phase_3","mechanism":"Avastin (bevacizumab) is a monoclonal antibody that blocks vascular endothelial growth factor (VEGF), preventing tumor blood vessel formation and starving tumors of oxygen and nutrients.","indications":["Metastatic colorectal cancer","Metastatic non-small cell lung cancer","Metastatic breast cancer","Glioblastoma","Metastatic renal cell carcinoma"],"catalyst":""},{"name":"US Sourced Avastin®","genericName":"US Sourced Avastin®","slug":"us-sourced-avastin","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxONmtKVXJsUVhaS0tQZlBKV1ZGeU1faTJ2TFdEaGx5Ri1ZcGktS2FxOTlpdVY1cUROc2pkQ01QdWFQSlFLalExSlN2Ujc3S0lSdHRRNTVrcG5WdG14cEdkWlk5cUpXNmp3VG00eHZIc1pZWmhESmxORmM3QVh0endqbk5hOUY5bWx5RE1uanpkRWM1bF9Wc0loS0tzdGpGQ1h4YUE?oc=5","date":"2026-02-17","type":"deal","source":"LinkedIn","summary":"\"The reason we chose Cipla for partnership is that it has a strong distribution network across India. They have reach in areas we are not located. This will help us reach more patients,\" said Winselow","headline":"\"The reason we chose Cipla for partnership is that it has a strong distribution network across India. They have reach in","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxQM3cyVkE0TGF2cnZYZk1PRzI0WXVYeFVXcUxiZTBSWDB4ZHdlb3dNRU52eGhaVDVzYi02UzlzOHBhbVVZaW9feGc0UF9xbGIxUDlhR05uVEhmMDdYYThLXzBQLWxRWWVjU2dlaUlzWUZEVjhDNW9HR3ZucFpZYkdmSzZhQTR5X1ZlR0NoUGQ2eWpjTlZyZVZKUE51RWlLUURyTW5MWmFjZnY4ZTNnZ0xFUVdycktlc2lnazlPdU83ODNNYW1YZ20wSWNlVUNWSVJ2Y0Z5VDB1bF_SAd4BQVVfeXFMT29iVkQtNWZrendmbmpQTlpYQ0hnVkJBTnlNNkltQzFkSWlZZUlCblJVVjlvbGp6QXgxVzdlRXRiTjU5TnhVUEQwczdhYUswWjhiaGE2UHVFVWJJaGI4T05HNmJvS1JuTGZlc3FWMFZab1B5NFAySGh1a1FGeWIwT0JlZXZLNWR4N1YzaFVQMHFEaUxFUXl0RUZzWkQ4UFVJZmRCakZlZlJRVUV3cmVwN1dWV3g4NmJlQ0JDTk82Z09pX0tJZi1QSWszX2J1aEJuenJUYTUxMTI0UlhpckFn?oc=5","date":"2025-12-29","type":"pipeline","source":"Business Standard","summary":"Antique prefers domestic-focused pharma firms; resumes coverage on 4 stocks - Business Standard","headline":"Antique prefers domestic-focused pharma firms; resumes coverage on 4 stocks","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-11","type":"patent","source":"The Economic Times","summary":"Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in China - The Economic Times","headline":"Cipla, Natco Pharma, Hetero Labs among Indian firms chosen to supply key generic drugs in China","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-30","type":"earnings","source":"The Economic Times","summary":"Cipla plans 4 major respiratory launches by 2026 after beating Q2 estimates with highest-ever quarterly re - The Economic Times","headline":"Cipla plans 4 major respiratory launches by 2026 after beating Q2 estimates with highest-ever quarterly re","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPWW0xckloU0J2WW1CYjBCOVY0SVUydlF6aTQxTWtPbGRhcWhlekVLeENrelBwZDF5a1IwSFlmM0VqLWFENmxOY3dlX3I4WUF0UjB4emEyMk1VUlJCeU1iVk1NeUpOSFgzMGJRem1GMzdfRDQ2UXRpZS1IMmdWNFYtWUJNM1BHdUxiM0F2elc4annSAZYBQVVfeXFMTkpldWhmU2wtMXZBVVlRcDliaExHMUxkWE54YUVQb1U5NkRubXRhaFJDMlpmWU14emtUQWxVUk5oNmJsbGQ4cVNBM3ZGUlZZT2IxSFE4SENWTTFDNGpSSEFmbEJSd0dKTjlleDA4bmRvQ3RITWoxdzZDNzJXZzNWVVlHaXc1R0NVU2V6aWZIdkxMUHQybGJB?oc=5","date":"2025-10-30","type":"pipeline","source":"Express Pharma","summary":"Cipla names Achin Gupta as MD & GCEO effective April 1, 2026 - Express Pharma","headline":"Cipla names Achin Gupta as MD & GCEO effective April 1, 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPOEVxUHNEM0hyQ1hZVXlqZ2JsdHFTV2pfSGZjUms2VlFBVlZrUXRuVTk0Ykt3S1NnUEduVzZIRk5zUzVBTXVEcGdXeWJEbzViem1LVHBxMnUwUGRhVWdVTW92cERJay10V21FcG1nb2l4bVd6R3BPTDhQdTdTT3F5UVZvbzg?oc=5","date":"2025-05-31","type":"deal","source":"HDFC Sky","summary":"Cipla Subsidiary Acquires 26% Stake in AMPIN Solar Project - HDFC Sky","headline":"Cipla Subsidiary Acquires 26% Stake in AMPIN Solar Project","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9HdEV6Q0k5N2k0SHhPejQ2LWUyaUgxTjRFZHVFU2J0MDlweGxjb182M05wNnp4R1Z6YzktdjhCekZ5UG5XNmVmcncyMW0wSFRKMFljbjBUUHQ5d09VS2pVcDNESERIOWs?oc=5","date":"2025-04-29","type":"pipeline","source":"lpu.in","summary":"BTech Biotechnology: Scope, Salary & Careers - lpu.in","headline":"BTech Biotechnology: Scope, Salary & Careers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNVzYwQThyeWpYR2xGa2F6cDdmLXBPZ3hOQXl6Mm1BWkRiTzQ4eGR4UzNYMFdGU1NrWjVSakZRS3pueHdkYWNpT2xiTzd0S0hSczBZRXJKUnhrQ2RRQnJLSHM3QnRFS3htZU53ZGtXa0tRNENnQlZycllkdVZDSzJzcF9sQnJBaWRxUlFvZkJLYXdCbWFaRmk5RG1pMGgySEZzTXZQUXVYVmFtdHJrWEZPMGc0YWRONU5fd25Sc0NjbFZtY1dJbDJpT29QYzM?oc=5","date":"2024-09-04","type":"pipeline","source":"ehealth.eletsonline.com","summary":"Celebrating Pharma Excellence & Innovation: The 6th Elets Pharma Leadership Summit & Awards 2024 - ehealth.eletsonline.com","headline":"Celebrating Pharma Excellence & Innovation: The 6th Elets Pharma Leadership Summit & Awards 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE03blBhczVDNTZ1dWZYMm41MXBITTc2ck5xUG9MRy1fcVB6dUFZTkNqZ2lSaW9XRGFPMHVaVTJGT2VNWGhoc3dGWnpvUWtZVEtyNmVCdHZnZ011TW9FT19uTHhTMUloRlZJNWc?oc=5","date":"2024-05-15","type":"pipeline","source":"Built In","summary":"21 Top Pharma Companies in India to Know - Built In","headline":"21 Top Pharma Companies in India to Know","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-01-09","type":"pipeline","source":"Medical Dialogues","summary":"Cipla, Kemwell Biopharma, Manipal forge cell therapy alliance in US - Medical Dialogues","headline":"Cipla, Kemwell Biopharma, Manipal forge cell therapy alliance in US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBQNXY3eUEyeXFZME1ScTc0TkRMbTlueFhJMG1OWHVVRkg1MHBZZUx3N1ZmOHY3NlFvTFVwaEZ3MzczdzcyeWltSjhFS3FVU3kxZ1Nwa0ZRUDhKRDhN?oc=5","date":"2021-04-17","type":"pipeline","source":"TradingView","summary":"CIPLA Stock Price and Chart — LUXSE:CIPLA - TradingView","headline":"CIPLA Stock Price and Chart — LUXSE:CIPLA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPeWhqZ3ZMSVBUT2Exb2EtWTJZZjdtdnYtVTNfUHkxUWwxVzlkZHBpUXZtRkNqcmdsRnNJNmxMNWNZUEMzQi1nSHRkb0VwQ3BZclZIOGpXYWZQX2I5NDFvY1NEbFI3V3NhSXNoS1VrSTZnanM1akgtX1U1cVZYcWJKQ0lYdkdpaHlEWnpfTUFzTXVpQ1pybXdz?oc=5","date":"2016-09-23","type":"patent","source":"VCCircle","summary":"Cipla BioTec hires banker for biggest PE fundraise in biosimilar space - VCCircle","headline":"Cipla BioTec hires banker for biggest PE fundraise in biosimilar space","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"phase_1":1},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}